ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.557,27
-0,48%
S&P 500
5.346,99
-0,11%
Dow Jones
38.798,99
-0,22%
Euro vs US Dollar
1,08165
-0,69%
Bitcoin
69.339,23
-2,01%
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. AMEX
  6. Azitra Inc (AZTR)

  7. Azitra Inc (AZTR) News

AZTR

Azitra (AZTR)

Azitra Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:AMEX:AZTR
DatumZeitQuelleÜberschriftSymbolFirma
03/06/202422h30Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsAMEX:AZTRAzitra Inc
31/05/202414h00Business WireAzitra, Inc. Announces Presentation at the 2024 BIO International ConventionAMEX:AZTRAzitra Inc
24/05/202422h55Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsAMEX:AZTRAzitra Inc
17/05/202414h00Business WireAzitra, Inc. Announces Positive Preclinical Data from ATR-04 Presented at the Society of Investigative Dermatology Annual MeetingAMEX:AZTRAzitra Inc
10/05/202414h00Business WireAzitra, Inc. Announces Positive Preclinical Data of ATR-12 and Clinical Design in Netherton Syndrome Presented at the ASGCT Annual MeetingAMEX:AZTRAzitra Inc
09/05/202423h05Edgar (US Regulatory)Form 8-K - Current reportAMEX:AZTRAzitra Inc
09/05/202423h03Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]AMEX:AZTRAzitra Inc
09/05/202423h00Business WireAzitra, Inc. Announces Q1 2024 Financial Results and Provides Business UpdatesAMEX:AZTRAzitra Inc
22/04/202422h30Business WireAzitra, Inc. Announces New Preclinical Data to be Presented at the American Society of Gene and Cell Therapy MeetingAMEX:AZTRAzitra Inc
18/04/202422h15Business WireAzitra, Inc. to Present New Data at Three Upcoming Scientific Conferences in May 2024AMEX:AZTRAzitra Inc
15/03/202421h15Business WireAzitra, Inc. Announces Full Year 2023 Financial Results and Provides Business UpdatesAMEX:AZTRAzitra Inc
26/02/202422h10Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]AMEX:AZTRAzitra Inc
26/02/202422h05Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsAMEX:AZTRAzitra Inc
16/02/202422h05Business WireAzitra, Inc. Announces Closing of Public OfferingAMEX:AZTRAzitra Inc
16/02/202402h42Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:AZTRAzitra Inc
16/02/202402h39Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:AZTRAzitra Inc
16/02/202402h38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:AZTRAzitra Inc
15/02/202422h44Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]AMEX:AZTRAzitra Inc
14/02/202415h15Edgar (US Regulatory)Form 8-K - Current reportAMEX:AZTRAzitra Inc
14/02/202404h09Business WireAzitra, Inc. Announces Pricing of Public OfferingAMEX:AZTRAzitra Inc
19/01/202417h08Edgar (US Regulatory)Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectusesAMEX:AZTRAzitra Inc
19/01/202415h19Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933AMEX:AZTRAzitra Inc
16/01/202415h00Business WireAzitra, Inc. Strengthens Intellectual Property Portfolio with Newly Granted Patent in the USAMEX:AZTRAzitra Inc
03/01/202415h00Business WireAzitra, Inc. to Present at Biotech Showcase 2024 and the Dermatology Summit 2024, Alongside the J.P. Morgan Annual Healthcare ConferenceAMEX:AZTRAzitra Inc
04/12/202322h06Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansAMEX:AZTRAzitra Inc
14/11/202322h30Business WireAzitra, Inc. Announces Third Quarter 2023 Financial Results and Business UpdatesAMEX:AZTRAzitra Inc
16/10/202314h00Business WireAzitra to Present at the ThinkEquity ConferenceAMEX:AZTRAzitra Inc
03/10/202322h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:AZTRAzitra Inc
03/10/202322h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:AZTRAzitra Inc
03/10/202322h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesAMEX:AZTRAzitra Inc
 Showing the most relevant articles for your search:AMEX:AZTR

Kürzlich von Ihnen besucht

NASDAQ
AAYOJXX
Jpmorgan Chase Bank Na P...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten